REXAHN PHARMACEUTICALS INC's ticker is RNN and the CUSIP is 761640200. A total of 28 filers reported holding REXAHN PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $18,000 | -43.8% | 34,767 | 0.0% | 0.00% | – |
| Q4 2018 | $32,000 | -48.4% | 34,767 | 0.0% | 0.00% | -100.0% |
| Q3 2018 | $62,000 | +26.5% | 34,767 | 0.0% | 0.00% | – |
| Q2 2018 | $49,000 | -5.8% | 34,767 | 0.0% | 0.00% | – |
| Q1 2018 | $52,000 | -47.5% | 34,767 | -29.3% | 0.00% | -100.0% |
| Q4 2017 | $99,000 | -16.8% | 49,167 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $119,000 | – | 49,167 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| HUDSON VALLEY INVESTMENT ADVISORS INC /ADV | 0 | $0 | 0.00% |